Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6105-6121
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6105
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6105
Unstandardized coefficients | Standardized coefficients | t-value | P value | |||
B | Std. Error | Beta | Std. Error | |||
(Constant) | 0.806 | 1.297 | 0.621 | 0.535 | ||
Age | 0.003 | 0.001 | 0.098 | 0.053 | 1.835 | 0.068 |
Gender | 0.029 | 0.044 | 0.038 | 0.058 | 0.652 | 0.515 |
No of co-morbidities | -0 | 0.015 | -0.01 | 0.048 | -0.144 | 0.885 |
Severity of COVID | -0 | 0.036 | -0.01 | 0.059 | -0.123 | 0.903 |
No of symptoms | 0.029 | 0.033 | 0.049 | 0.057 | 0.854 | 0.394 |
Macrolide | -0.03 | 0.083 | -0.03 | 0.074 | -0.362 | 0.718 |
Fluroquinolones | 0.001 | 0.068 | 0.001 | 0.073 | 0.02 | 0.984 |
Cephalosporin | 0.046 | 0.071 | 0.052 | 0.081 | 0.646 | 0.519 |
Carbapenems | 0.057 | 0.07 | 0.065 | 0.08 | 0.818 | 0.415 |
Amox/calv | -0.19 | 0.398 | -0.02 | 0.039 | -0.479 | 0.632 |
Linezolid | -0.01 | 0.072 | -0.01 | 0.058 | -0.097 | 0.923 |
Teicoplanin | -0.2 | 0.316 | -0.03 | 0.044 | -0.636 | 0.526 |
Other Antibiotics | -0.03 | 0.105 | -0.01 | 0.043 | -0.274 | 0.784 |
Anticoagulant | -0.1 | 0.099 | -0.07 | 0.067 | -1.033 | 0.303 |
Prophylaxis/therapeutic | -0.01 | 0.048 | -0.02 | 0.063 | -0.298 | 0.766 |
Antiplatelet | -0.03 | 0.083 | -0.02 | 0.06 | -0.34 | 0.734 |
Steroids | -0.04 | 0.078 | -0.04 | 0.065 | -0.561 | 0.576 |
Additive therapy | 0.096 | 0.12 | 0.041 | 0.051 | 0.803 | 0.423 |
Paracetamol | -0.05 | 0.095 | -0.02 | 0.05 | -0.475 | 0.635 |
Zinc | -0.1 | 0.084 | -0.06 | 0.049 | -1.21 | 0.228 |
Acetylcysteine | -0.03 | 0.176 | -0.01 | 0.052 | -0.151 | 0.88 |
Lactoferrin | 0.312 | 0.237 | 0.092 | 0.07 | 1.315 | 0.19 |
Vitamin C | 0.044 | 0.072 | 0.031 | 0.05 | 0.615 | 0.539 |
Nasal prongs use | -0 | 0.043 | -0.01 | 0.055 | -0.083 | 0.934 |
FM use | 0.04 | 0.053 | 0.046 | 0.06 | 0.764 | 0.446 |
MR use | -0.03 | 0.05 | -0.03 | 0.054 | -0.538 | 0.591 |
HFNC use | 0.004 | 0.05 | 0.003 | 0.048 | 0.071 | 0.944 |
CPAP | 0.003 | 0.092 | 0.004 | 0.101 | 0.035 | 0.972 |
vasopressor | 0.054 | 0.093 | 0.042 | 0.072 | 0.579 | 0.563 |
Prone position | -0.18 | 0.105 | -0.08 | 0.046 | -1.74 | 0.084 |
PaO2 | -0 | 0.001 | -0.19 | 0.067 | -2.841 | 0.005 |
PaCO2 | -0.01 | 0.002 | -0.15 | 0.052 | -2.852 | 0.005 |
PaO2/Fio2 | 0.001 | 0 | 0.175 | 0.065 | 2.695 | 0.008 |
- Citation: Hegazy SK, Tharwat S, Hassan AH. Comparing the efficacy of regen-cov, remdesivir, and favipiravir in reducing invasive mechanical ventilation need in hospitalized COVID-19 patients. World J Clin Cases 2023; 11(26): 6105-6121
- URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6105.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6105